DK1407772T3 - Farmaceutisk præparat, der omfatter poröst sfærisk carbonholdigt stof, og dets anvendelse til behandling af nyre- og leversygdomme - Google Patents

Farmaceutisk præparat, der omfatter poröst sfærisk carbonholdigt stof, og dets anvendelse til behandling af nyre- og leversygdomme

Info

Publication number
DK1407772T3
DK1407772T3 DK02022633T DK02022633T DK1407772T3 DK 1407772 T3 DK1407772 T3 DK 1407772T3 DK 02022633 T DK02022633 T DK 02022633T DK 02022633 T DK02022633 T DK 02022633T DK 1407772 T3 DK1407772 T3 DK 1407772T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
porous spherical
carbonaceous substance
spherical carbonaceous
kidney
Prior art date
Application number
DK02022633T
Other languages
Danish (da)
English (en)
Inventor
Hideyuki Yamato
Haruhisa Hayashi
Satoshi Mitsuhashi
Michihito Ise
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Application granted granted Critical
Publication of DK1407772T3 publication Critical patent/DK1407772T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK02022633T 2002-10-09 2002-10-09 Farmaceutisk præparat, der omfatter poröst sfærisk carbonholdigt stof, og dets anvendelse til behandling af nyre- og leversygdomme DK1407772T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02022633A EP1407772B9 (de) 2002-10-09 2002-10-09 Pharmazeutische Zubereitung enthaltend poröse sphärische kohlenstoffhaltige Teilchen und deren Verwendung zur Behandlung von Leber- und Nierenerkrankungen

Publications (1)

Publication Number Publication Date
DK1407772T3 true DK1407772T3 (da) 2006-12-11

Family

ID=32010951

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02022633T DK1407772T3 (da) 2002-10-09 2002-10-09 Farmaceutisk præparat, der omfatter poröst sfærisk carbonholdigt stof, og dets anvendelse til behandling af nyre- og leversygdomme

Country Status (5)

Country Link
EP (1) EP1407772B9 (de)
AT (1) ATE335495T1 (de)
DE (1) DE60213819T2 (de)
DK (1) DK1407772T3 (de)
ES (1) ES2269580T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI370012B (en) 2004-04-02 2012-08-11 Kureha Corp Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
TWI370013B (en) * 2004-04-02 2012-08-11 Kureha Corp Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
GB201204696D0 (en) 2012-03-16 2012-05-02 Ucl Business Plc Therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761284A (en) * 1977-12-27 1988-08-02 Kureha Kagaku Kogy Kabushiki Kaisha Antidote including activated carbon particles
JPS565313A (en) * 1979-06-26 1981-01-20 Kureha Chem Ind Co Ltd Detoxificating spherical active carbon and preparing the same
JPS5673542A (en) * 1979-11-22 1981-06-18 Kureha Chem Ind Co Ltd Adsorbent
JP3518878B2 (ja) * 1992-10-29 2004-04-12 呉羽化学工業株式会社 抗ネフローゼ症候群剤
CA2162086A1 (en) * 1994-11-15 1996-05-16 Michihito Ise Agent for reducing nephrotoxicity due to medicine
JP3522708B2 (ja) * 2001-04-11 2004-04-26 呉羽化学工業株式会社 経口投与用吸着剤

Also Published As

Publication number Publication date
EP1407772A1 (de) 2004-04-14
EP1407772B1 (de) 2006-08-09
DE60213819D1 (de) 2006-09-21
ATE335495T1 (de) 2006-09-15
DE60213819T2 (de) 2007-08-09
ES2269580T3 (es) 2007-04-01
EP1407772B9 (de) 2007-02-21

Similar Documents

Publication Publication Date Title
HK1076035A1 (en) Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
DK1249241T3 (da) Adsorbent til oral indgivelse
JP2005532372A5 (de)
CL2008003941A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden compulsivo obsesivo.
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
RS50876B (sr) Upotreba flibanserina u lečenju seksualnih poremećaja
JP2003506527A5 (de)
DE10085464T1 (de) Poröser Kohlenstoffkörper mit erhöhter Benetzbarkeit durch Wasser
IL145068A0 (en) The use of glycine betaine to prepare a pharmaceutical composition
WO2003031324A3 (en) Activated, coal-based carbon foam
DK1225881T3 (da) Anvendelsen af dapoxetin, en hurtigt-virkende selektiv serotonin genoptagelseshæmmer, til behandling af seksuel dysfunktion
BRPI0417714A (pt) composto, composição farmacêutica, e, uso de um composto
DK1407772T3 (da) Farmaceutisk præparat, der omfatter poröst sfærisk carbonholdigt stof, og dets anvendelse til behandling af nyre- og leversygdomme
SE0203687D0 (sv) Pharmaceutical Porous Particles
ATE392900T1 (de) Verwendung unverdaulicher, polymerer schäume zum abkapseln eingenommener stoffe, und dadurch verhinderung ihre aufnahme durch den körper
KR950031090A (ko) 치질 치료용 약제학적 조성물
JP2003522147A5 (de)
EA200401454A1 (ru) Новая комбинация из обратимо действующих ингибиторов протонного насоса и используемых в терапии дыхательных путей лекарственных веществ, предназначенных для лечения респираторных заболеваний
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
TW200500084A (en) Adsorbent for oral administration and pharmaceutical composition, and method of manufacturing absorbent for oral administration
JPH0217293U (de)
WO2003024568A3 (en) Air purifying procedure and saline material of spongy structure
JPS62178642A (ja) 建材
XU et al. Characteristics of 2, 4-dichlorophenol adsorption by bamboo-carbon and affecting factors
CA2304899A1 (en) New use of selective serotonin reuptake inhibitors for treatment of human patients with chest pain of non-cardiac origin or with gastro-esophageal reflux disease